Microglial pro-inflammatory mechanisms induced by monomeric C-reactive protein are counteracted by soluble epoxide hydrolase inhibitors.

Saved in:
Bibliographic Details
Title: Microglial pro-inflammatory mechanisms induced by monomeric C-reactive protein are counteracted by soluble epoxide hydrolase inhibitors.
Authors: Bartra C; Department of Neuroscience and Experimental Therapeutics, Institute of Biomedical Research of Barcelona (IIBB), CSIC, 08036 Barcelona, Spain; PhD Program in Biotechnology, Facultat de Farmàcia i Ciències de l'Alimentació, Universitat de Barcelona, 08034 Barcelona, Spain. Electronic address: clara.bartra@iibb.csic.es., Vuraić K; Department of Neuroscience and Experimental Therapeutics, Institute of Biomedical Research of Barcelona (IIBB), CSIC, 08036 Barcelona, Spain., Yuan Y; Department of Neuroscience and Experimental Therapeutics, Institute of Biomedical Research of Barcelona (IIBB), CSIC, 08036 Barcelona, Spain., Codony S; Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain; Institute of Biomedicine of the University of Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain., Valdés-Quiroz H; Department of Neuroscience and Experimental Therapeutics, Institute of Biomedical Research of Barcelona (IIBB), CSIC, 08036 Barcelona, Spain., Casal C; Microscopy Service, Institute of Biomedical Research of Barcelona (IIBB), CSIC, Barcelona, Spain., Slevin M; CCAMF, George Emil Palade Universitatea de Medicina, Farmacie, Stiinte se Technologie, 'George Emil Palade' din Targu-Mures, 540142, Tirgu Mures, Romania., Máquez-Kisinousky L; Department of Neuroscience and Experimental Therapeutics, Institute of Biomedical Research of Barcelona (IIBB), CSIC, 08036 Barcelona, Spain., Planas AM; Department of Neuroscience and Experimental Therapeutics, Institute of Biomedical Research of Barcelona (IIBB), CSIC, 08036 Barcelona, Spain., Griñán-Ferré C; Department of Pharmacology and Therapeutic Chemistry, Institut de Neurociències-Universitat de Barcelona, Barcelona, Spain; Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Pallàs M; Department of Pharmacology and Therapeutic Chemistry, Institut de Neurociències-Universitat de Barcelona, Barcelona, Spain; Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain., Morisseau C; Department of Entomology and Nematology and Comprehensive Cancer Center, University of California, Davis, CA 95616, United States., Hammock BD; Department of Entomology and Nematology and Comprehensive Cancer Center, University of California, Davis, CA 95616, United States., Vázquez S; Laboratory of Medicinal Chemistry (CSIC Associated Unit), Faculty of Pharmacy and Food Sciences, Universitat de Barcelona, Barcelona, Spain; Institute of Biomedicine of the University of Barcelona (IBUB), Universitat de Barcelona, Barcelona, Spain., Suñol C; Department of Neuroscience and Experimental Therapeutics, Institute of Biomedical Research of Barcelona (IIBB), CSIC, 08036 Barcelona, Spain., Sanfeliu C; Department of Neuroscience and Experimental Therapeutics, Institute of Biomedical Research of Barcelona (IIBB), CSIC, 08036 Barcelona, Spain. Electronic address: coral.sanfeliu@iibb.csic.es.
Source: International immunopharmacology [Int Immunopharmacol] 2025 May 16; Vol. 155, pp. 114644. Date of Electronic Publication: 2025 Apr 10.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-1705
DOI:10.1016/j.intimp.2025.114644